A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
Clinical trial NCT02548585 · COMPLETED
Trial details
- NCT number
- NCT02548585
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-09
- Primary completion
- 2017-02-24
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.